Patents by Inventor Bernadette Wai

Bernadette Wai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-IL-12/IL-23 ANTIBODIES
    Publication number: 20140086922
    Abstract: Provided herein is an antibody comprising an antigen binding domain which binds to human IL-12 and human IL-23. The antibody binds human IL-12p40 existing as a monomer (human IL-12p40) and as a homodimer (human IL-12p80), and the antibody inhibits the binding of human IL-12 to human IL-12R?2 and human IL-23 to human IL-23R but does not inhibit the binding of human IL-12 or human IL-23 or human IL-12p40 or human IL-12p80 to human IL-12R?1.
    Type: Application
    Filed: September 18, 2013
    Publication date: March 27, 2014
    Inventors: Adam William Clarke, Anthony Gerard Doyle, Philip Anthony Jennings, Lynn Dorothy Poulton, Bernadette Wai, Andrew James Pow, George Kopsidas
  • Anti-IL-12/IL-23 antibodies
    Patent number: 8563697
    Abstract: The present invention provides an antibody comprising an antigen binding domain which binds to human IL-12 and human IL-23. The antibody binds human IL-12p40 existing as a monomer (human IL-12p40) and as a homodimer (human IL-12p80) and the antibody inhibits the binding of human IL-12 to human IL-12R ?2 and human IL-23 to human IL-23R but does not inhibit the binding of human IL-12 or human IL-23 or human IL-12p40 or human IL-12p80 to human IL-12R?1.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: October 22, 2013
    Assignee: Cephalon Australia Pty. Ltd.
    Inventors: Adam William Clarke, Anthony Gerard Doyle, Philip Anthony Jennings, Lynn Dorothy Poulton, Bernadette Wai, Andrew James Pow, George Kopsidas
  • ANTI-IL-12/IL-23 ANTIBODIES
    Publication number: 20110262445
    Abstract: The present invention provides an antibody comprising an antigen binding domain which binds to human IL-12 and human IL-23. The antibody binds human IL-12p40 existing as a monomer (human IL-12p40) and as a homodimer (human IL-12p80) and the antibody inhibits the binding of human IL-12 to human IL-12R ?2 and human IL-23 to human IL-23R but does not inhibit the binding of human IL-12 or human IL-23 or human IL-12p40 or human IL-12p80 to human IL-12R?1.
    Type: Application
    Filed: August 14, 2009
    Publication date: October 27, 2011
    Applicant: CEPHALON AUSTRALIA PTY LTD.
    Inventors: Adam William Clarke, Anthony Gerard Doyle, Philip Jennings, Lynn Dorothy Poulton, Bernadette Wai, Andrew James Pow